z-logo
open-access-imgOpen Access
Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial
Author(s) -
Marc A. Pfeffer,
Brian Claggett,
Eldrin F. Lewis,
Christopher B. Granger,
Lars Køber,
Aldo P. Maggioni,
Douglas L. Mann,
John J.V. McMurray,
JeanLucien Rouleau,
Scott D. Solomon,
Philippe Gabríel Steg,
Otávio Berwanger,
Maja Čikeš,
Carmine G. De Pasquale,
Alberto Fernández,
Gerasimos Filippatos,
Karola Jering,
Ulf Landmesser,
Venugopal Me,
Béla Merkely,
Mark C. Petrie,
Ivo Petrov,
Morten Schou,
Michele Senni,
David Sim,
Peter van der Meer,
Martin Lefkowitz,
Yig Zhou,
Yi Wang,
Eugene Braunwald
Publication year - 2021
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.121.057429
Subject(s) - medicine , sacubitril, valsartan , ramipril , heart failure , valsartan , cardiology , sacubitril , paradise , enalapril , angiotensin converting enzyme , ejection fraction , blood pressure , art , art history

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom